[1] MONTAGNA M T, CAGGIANO G, LOVERO G, et al. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)[J]. Infection,2013,41(3):645-653. [2] AEIAS S, DENIS O, MONTESINOS I, et al. Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study[J]. Eur J Clin Microbiol Infect Dis,2017,36(3):501-507. [3] PAPPAS P G, KAUFFMAN C A, ANDES D R, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis. 2016,62(4):e1-e50. [4] 曹云,宋少婷,李帅,等. 念珠菌血流感染临床与实验室特点分析[J].中国真菌学杂志,2019,14(1):7-10. [5] BAILLY S, MAUBON D, FOURNIER P, et al. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. trends over 10 years[J]. J Infect,2016,72(1):103-111. [6] 苏青青,顾洁,陈延斌. 光滑念珠菌血流感染20例临床分析[J].中国感染与化疗杂志,2020,20(1):23-26. [7] MORETTI M L, TRABASSO P, LYRA L, et al. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil[J]. Med Mycol, 2013,51(3):225-230. [8] 汪飞,周华,姚亚克,等. 氟康唑不敏感热带念珠菌血流感染患者的危险因素和预后分析[J].中华结核和呼吸杂志,2019,42(6):459-461. [9] 黄廷廷,夏文颖,许雨乔,等. 真菌血流感染患者死亡率相关危险因素分析[J].中国感染与化疗杂志,2020,20(5):465-469. [10] 赵淑贤. 回顾性分析念珠菌血症患者临床特征及预后危险因素[D].青岛:青岛大学,2020. [11] 赵越,袁凯旋,叶龙,等. 165例老年念珠菌血症患者的临床特征分析及预后评价[J].重庆医科大学学报,2020,45(10):1484-1486. [12] MURRI R, CAMICI M, POSTERARO B, et al.Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients[J]. Infect Drug Resist, 2019, 12:19-24. DOI:10.2147/DOI,S181489. [13] 中国成人念珠菌病诊断与治疗专家共识组. 中国成人念珠菌病诊断与治疗专家共识[J]. 中华内科杂志,2020,59(1):5-17. |